Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Innovative methods to summarize nursing home antibiotic data.

Felsen CB, Barney GR, Dumyati GK.

Infect Control Hosp Epidemiol. 2019 Oct;40(10):1210-1211. doi: 10.1017/ice.2019.226. Epub 2019 Jul 30. No abstract available.

PMID:
31358073
2.

Bacterial and Fungal Infections in Persons Who Inject Drugs - Western New York, 2017.

Hartnett KP, Jackson KA, Felsen C, McDonald R, Bardossy AC, Gokhale RH, Kracalik I, Lucas T, McGovern O, Van Beneden CA, Mendoza M, Bohm M, Brooks JT, Asher AK, Magill SS, Fiore A, Blog D, Dufort EM, See I, Dumyati G.

MMWR Morb Mortal Wkly Rep. 2019 Jul 5;68(26):583-586. doi: 10.15585/mmwr.mm6826a2.

3.

Public Health Importance of Invasive Methicillin-sensitive Staphylococcus aureus Infections: Surveillance in 8 US Counties, 2016.

Jackson KA, Gokhale RH, Nadle J, Ray SM, Dumyati G, Schaffner W, Ham DC, Magill SS, Lynfield R, See I.

Clin Infect Dis. 2019 Apr 23. pii: ciz323. doi: 10.1093/cid/ciz323. [Epub ahead of print]

PMID:
31245810
4.

Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015.

Walters MS, Grass JE, Bulens SN, Hancock EB, Phipps EC, Muleta D, Mounsey J, Kainer MA, Concannon C, Dumyati G, Bower C, Jacob J, Cassidy PM, Beldavs Z, Culbreath K, Phillips WE Jr, Hardy DJ, Vargas RL, Oethinger M, Ansari U, Stanton R, Albrecht V, Halpin AL, Karlsson M, Rasheed JK, Kallen A.

Emerg Infect Dis. 2019 Jul;25(7):1281-1288. doi: 10.3201/eid2507.181200.

5.

Risk factors for community-associated Clostridioides difficile infection in young children.

Weng MK, Adkins SH, Bamberg W, Farley MM, Espinosa CC, Wilson L, Perlmutter R, Holzbauer S, Whitten T, Phipps EC, Hancock EB, Dumyati G, Nelson DS, Beldavs ZG, Ocampo V, Davis CM, Rue B, Korhonen L, McDonald LC, Guh AY.

Epidemiol Infect. 2019 Jan;147:e172. doi: 10.1017/S0950268819000372.

6.

Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections - United States.

Kourtis AP, Hatfield K, Baggs J, Mu Y, See I, Epson E, Nadle J, Kainer MA, Dumyati G, Petit S, Ray SM; Emerging Infections Program MRSA author group, Ham D, Capers C, Ewing H, Coffin N, McDonald LC, Jernigan J, Cardo D.

MMWR Morb Mortal Wkly Rep. 2019 Mar 8;68(9):214-219. doi: 10.15585/mmwr.mm6809e1.

7.

A Nationwide Screen of Carbapenem-Resistant Klebsiella pneumoniae Reveals an Isolate with Enhanced Virulence and Clinically Undetected Colistin Heteroresistance.

Wozniak JE, Band VI, Conley AB, Rishishwar L, Burd EM, Satola SW, Hardy DJ, Tsay R, Farley MM, Jacob JT, Dumyati G, Jordan IK, Weiss DS.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e00107-19. doi: 10.1128/AAC.00107-19. Print 2019 May.

8.

Trends in incidence of methicillin-resistant Staphylococcus aureus bloodstream infections differ by strain type and healthcare exposure, United States, 2005-2013.

See I, Mu Y, Albrecht V, Karlsson M, Dumyati G, Hardy DJ, Koeck M, Lynfield R, Nadle J, Ray SM, Schaffner W, Kallen AJ.

Clin Infect Dis. 2019 Feb 25. pii: ciz158. doi: 10.1093/cid/ciz158. [Epub ahead of print]

PMID:
30801635
9.

Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.

Guh AY, Hatfield KM, Winston LG, Martin B, Johnston H, Brousseau G, Farley MM, Wilson L, Perlmutter R, Phipps EC, Dumyati GK, Nelson D, Hatwar T, Kainer MA, Paulick AL, Karlsson M, Gerding DN, McDonald LC.

Clin Infect Dis. 2019 Oct 30;69(10):1667-1674. doi: 10.1093/cid/ciz009.

PMID:
30615074
10.

Antimicrobial Susceptibility Trends Observed in Urinary Pathogens Obtained From New York State.

Rank EL, Lodise T, Avery L, Bankert E, Dobson E, Dumyati G, Hassett S, Keller M, Pearsall M, Lubowski T, Carreno JJ.

Open Forum Infect Dis. 2018 Nov 16;5(11):ofy297. doi: 10.1093/ofid/ofy297. eCollection 2018 Nov.

11.

One-day point prevalence as a method for estimating antibiotic use in nursing homes.

Barney GR, Felsen CB, Dumyati GK.

Infect Control Hosp Epidemiol. 2019 Feb;40(2):221-223. doi: 10.1017/ice.2018.309. Epub 2018 Dec 5.

PMID:
30516118
12.

Changes in Prevalence of Health Care-Associated Infections in U.S. Hospitals.

Magill SS, O'Leary E, Janelle SJ, Thompson DL, Dumyati G, Nadle J, Wilson LE, Kainer MA, Lynfield R, Greissman S, Ray SM, Beldavs Z, Gross C, Bamberg W, Sievers M, Concannon C, Buhr N, Warnke L, Maloney M, Ocampo V, Brooks J, Oyewumi T, Sharmin S, Richards K, Rainbow J, Samper M, Hancock EB, Leaptrot D, Scalise E, Badrun F, Phelps R, Edwards JR; Emerging Infections Program Hospital Prevalence Survey Team.

N Engl J Med. 2018 Nov 1;379(18):1732-1744. doi: 10.1056/NEJMoa1801550.

PMID:
30380384
13.

Burden of Invasive Methicillin-Resistant Staphylococcus aureus Infections in Nursing Home Residents.

Grigg C, Palms D, Stone ND, Gualandi N, Bamberg W, Dumyati G, Harrison LH, Lynfield R, Nadle J, Petit S, Ray S, Schaffner W, Townes J, See I.

J Am Geriatr Soc. 2018 Aug;66(8):1581-1586. doi: 10.1111/jgs.15451. Epub 2018 Aug 10.

PMID:
30094828
14.

A Tale of Two Healthcare-associated Infections: Clostridium difficile Coinfection Among Patients With Candidemia.

Tsay S, Williams SR, Benedict K, Beldavs Z, Farley M, Harrison L, Schaffner W, Dumyati G, Blackstock A, Guh A, Vallabhaneni S.

Clin Infect Dis. 2019 Feb 1;68(4):676-679. doi: 10.1093/cid/ciy607.

15.

Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Persons Who Inject Drugs - Six Sites, 2005-2016.

Jackson KA, Bohm MK, Brooks JT, Asher A, Nadle J, Bamberg WM, Petit S, Ray SM, Harrison LH, Lynfield R, Dumyati G, Schaffner W, Townes JM, See I.

MMWR Morb Mortal Wkly Rep. 2018 Jun 8;67(22):625-628. doi: 10.15585/mmwr.mm6722a2.

16.

Risk Factors for Community-Associated Clostridium difficile Infection in Adults: A Case-Control Study.

Guh AY, Adkins SH, Li Q, Bulens SN, Farley MM, Smith Z, Holzbauer SM, Whitten T, Phipps EC, Hancock EB, Dumyati G, Concannon C, Kainer MA, Rue B, Lyons C, Olson DM, Wilson L, Perlmutter R, Winston LG, Parker E, Bamberg W, Beldavs ZG, Ocampo V, Karlsson M, Gerding DN, McDonald LC.

Open Forum Infect Dis. 2017 Oct 26;4(4):ofx171. doi: 10.1093/ofid/ofx171. eCollection 2017 Fall.

17.

Racial Disparities in Invasive Methicillin-resistant Staphylococcus aureus Infections, 2005-2014.

Gualandi N, Mu Y, Bamberg WM, Dumyati G, Harrison LH, Lesher L, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, McDonald M, See I.

Clin Infect Dis. 2018 Sep 28;67(8):1175-1181. doi: 10.1093/cid/ciy277.

18.

Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015.

Bulens SN, Yi SH, Walters MS, Jacob JT, Bower C, Reno J, Wilson L, Vaeth E, Bamberg W, Janelle SJ, Lynfield R, Vagnone PS, Shaw K, Kainer M, Muleta D, Mounsey J, Dumyati G, Concannon C, Beldavs Z, Cassidy PM, Phipps EC, Kenslow N, Hancock EB, Kallen AJ.

Emerg Infect Dis. 2018 Apr;24(4):727-734. doi: 10.3201/eid2404.171461.

19.

Trends in incidence of long-term-care facility onset Clostridium difficile infections in 10 US geographic locations during 2011-2015.

Guh AY, Mu Y, Baggs J, Winston LG, Bamberg W, Lyons C, Farley MM, Wilson LE, Holzbauer SM, Phipps EC, Beldavs ZG, Kainer MA, Karlsson M, Gerding DN, Dumyati G.

Am J Infect Control. 2018 Jul;46(7):840-842. doi: 10.1016/j.ajic.2017.11.026. Epub 2018 Jan 9.

20.

Template for an Antibiotic Stewardship Policy for Post-Acute and Long-Term Care Settings.

Jump RLP, Gaur S, Katz MJ, Crnich CJ, Dumyati G, Ashraf MS, Frentzel E, Schweon SJ, Sloane P, Nace D; Infection Advisory Committee for AMDA—The Society of Post-Acute and Long-Term Care Medicine.

J Am Med Dir Assoc. 2017 Nov 1;18(11):913-920. doi: 10.1016/j.jamda.2017.07.018. Epub 2017 Sep 19. Review.

21.

Risk factors for carbapenem-nonsusceptible Pseudomonas aeruginosa: Case-control study.

Khadem T, Stevens V, Holt K, Hoffmann C, Dumyati G, Brown J.

Diagn Microbiol Infect Dis. 2017 Oct;89(2):146-150. doi: 10.1016/j.diagmicrobio.2017.06.017. Epub 2017 Jul 1.

PMID:
28780998
22.

Measuring Antibiotic Appropriateness for Urinary Tract Infections in Nursing Home Residents.

Eure T, LaPlace LL, Melchreit R, Maloney M, Lynfield R, Whitten T, Warnke L, Dumyati G, Quinlan G, Concannon C, Thompson D, Stone ND, Thompson ND.

Infect Control Hosp Epidemiol. 2017 Aug;38(8):998-1001. doi: 10.1017/ice.2017.96. Epub 2017 May 31.

PMID:
28560933
23.

Challenges and Strategies for Prevention of Multidrug-Resistant Organism Transmission in Nursing Homes.

Dumyati G, Stone ND, Nace DA, Crnich CJ, Jump RL.

Curr Infect Dis Rep. 2017 Apr;19(4):18. doi: 10.1007/s11908-017-0576-7. Review.

24.

Socioeconomic Factors Explain Racial Disparities in Invasive Community-Associated Methicillin-Resistant Staphylococcus aureus Disease Rates.

See I, Wesson P, Gualandi N, Dumyati G, Harrison LH, Lesher L, Nadle J, Petit S, Reisenauer C, Schaffner W, Tunali A, Mu Y, Ahern J.

Clin Infect Dis. 2017 Mar 1;64(5):597-604. doi: 10.1093/cid/ciw808.

25.

Prevalence of Antimicrobial Use and Opportunities to Improve Prescribing Practices in U.S. Nursing Homes.

Thompson ND, LaPlace L, Epstein L, Thompson D, Dumyati G, Concannon C, Quinlan G, Witten T, Warnke L, Lynfield R, Maloney M, Melchreit R, Stone ND.

J Am Med Dir Assoc. 2016 Dec 1;17(12):1151-1153. doi: 10.1016/j.jamda.2016.08.013. Epub 2016 Oct 14.

26.

Comparison of Data Collection for Healthcare-Associated Infection Surveillance in Nursing Homes.

Epstein L, Stone ND, LaPlace L, Harper J, Lynfield R, Warnke L, Whitten T, Maloney M, Melchreit R, Rodriguez R, Quinlan G, Concannon C, Dumyati G, Thompson DL, Thompson N.

Infect Control Hosp Epidemiol. 2016 Dec;37(12):1440-1445. Epub 2016 Oct 3.

PMID:
27691989
27.

Vital Signs: Epidemiology of Sepsis: Prevalence of Health Care Factors and Opportunities for Prevention.

Novosad SA, Sapiano MR, Grigg C, Lake J, Robyn M, Dumyati G, Felsen C, Blog D, Dufort E, Zansky S, Wiedeman K, Avery L, Dantes RB, Jernigan JA, Magill SS, Fiore A, Epstein L.

MMWR Morb Mortal Wkly Rep. 2016 Aug 26;65(33):864-9. doi: 10.15585/mmwr.mm6533e1.

28.

Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes.

Hunter JC, Mu Y, Dumyati GK, Farley MM, Winston LG, Johnston HL, Meek JI, Perlmutter R, Holzbauer SM, Beldavs ZG, Phipps EC, Dunn JR, Cohen JA, Avillan J, Stone ND, Gerding DN, McDonald LC, Lessa FC.

Open Forum Infect Dis. 2016 Jan 18;3(1):ofv196. doi: 10.1093/ofid/ofv196. eCollection 2016 Jan.

29.

The Impact of Obesity and Diabetes on the Risk of Disease and Death due to Invasive Group A Streptococcus Infections in Adults.

Langley G, Hao Y, Pondo T, Miller L, Petit S, Thomas A, Lindegren ML, Farley MM, Dumyati G, Como-Sabetti K, Harrison LH, Baumbach J, Watt J, Van Beneden C.

Clin Infect Dis. 2016 Apr 1;62(7):845-52. doi: 10.1093/cid/civ1032. Epub 2015 Dec 23.

PMID:
26703865
30.

Completeness of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection Reporting From Outpatient Hemodialysis Facilities to the National Healthcare Safety Network, 2013.

Nguyen DB, See I, Gualandi N, Shugart A, Lines C, Bamberg W, Dumyati G, Harrison LH, Lesher L, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, Njord L, Sievert D, Thompson ND, Patel PR.

Infect Control Hosp Epidemiol. 2016 Feb;37(2):205-7. doi: 10.1017/ice.2015.265. Epub 2015 Nov 11.

31.

Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection.

Dantes R, Mu Y, Hicks LA, Cohen J, Bamberg W, Beldavs ZG, Dumyati G, Farley MM, Holzbauer S, Meek J, Phipps E, Wilson L, Winston LG, McDonald LC, Lessa FC.

Open Forum Infect Dis. 2015 Aug 11;2(3):ofv113. doi: 10.1093/ofid/ofv113. eCollection 2015 Sep.

32.

Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials.

Baggs J, Yousey-Hindes K, Ashley ED, Meek J, Dumyati G, Cohen J, Wise ME, McDonald LC, Lessa FC.

Vaccine. 2015 Nov 17;33(46):6241-9. doi: 10.1016/j.vaccine.2015.09.078. Epub 2015 Oct 9.

33.

Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013.

Guh AY, Bulens SN, Mu Y, Jacob JT, Reno J, Scott J, Wilson LE, Vaeth E, Lynfield R, Shaw KM, Vagnone PM, Bamberg WM, Janelle SJ, Dumyati G, Concannon C, Beldavs Z, Cunningham M, Cassidy PM, Phipps EC, Kenslow N, Travis T, Lonsway D, Rasheed JK, Limbago BM, Kallen AJ.

JAMA. 2015 Oct 13;314(14):1479-87. doi: 10.1001/jama.2015.12480.

34.

Risk Factors for Invasive Methicillin-Resistant Staphylococcus aureus Infection After Recent Discharge From an Acute-Care Hospitalization, 2011-2013.

Epstein L, Mu Y, Belflower R, Scott J, Ray S, Dumyati G, Felsen C, Petit S, Yousey-Hindes K, Nadle J, Pasutti L, Lynfield R, Warnke L, Schaffner W, Leib K, Kallen AJ, Fridkin SK, Lessa FC.

Clin Infect Dis. 2016 Jan 1;62(1):45-52. doi: 10.1093/cid/civ777. Epub 2015 Sep 3.

35.

Evaluating Epidemiology and Improving Surveillance of Infections Associated with Health Care, United States.

Magill SS, Dumyati G, Ray SM, Fridkin SK.

Emerg Infect Dis. 2015 Sep;21(9):1537-42. doi: 10.3201/eid2109.150508.

36.

Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae.

Chea N, Bulens SN, Kongphet-Tran T, Lynfield R, Shaw KM, Vagnone PS, Kainer MA, Muleta DB, Wilson L, Vaeth E, Dumyati G, Concannon C, Phipps EC, Culbreath K, Janelle SJ, Bamberg WM, Guh AY, Limbago B, Kallen AJ.

Emerg Infect Dis. 2015 Sep;21(9):1611-6. doi: 10.3201/eid2109.150198.

37.

Estimating central line-associated bloodstream infection incidence rates by sampling of denominator data: A prospective, multicenter evaluation.

Thompson ND, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Godine D, Maloney M, Kainer M, Ray S, Thompson D, Wilson L, Magill SS.

Am J Infect Control. 2015 Aug;43(8):853-6. doi: 10.1016/j.ajic.2015.03.031. Epub 2015 May 21.

38.

Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations.

Lessa FC, Mu Y, Winston LG, Dumyati GK, Farley MM, Beldavs ZG, Kast K, Holzbauer SM, Meek JI, Cohen J, McDonald LC, Fridkin SK.

Open Forum Infect Dis. 2014 Jul 28;1(2):ofu048. doi: 10.1093/ofid/ofu048. eCollection 2014 Sep.

39.

Burden of Clostridium difficile infection in the United States.

Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM, Meek JI, Phipps EC, Wilson LE, Winston LG, Cohen JA, Limbago BM, Fridkin SK, Gerding DN, McDonald LC.

N Engl J Med. 2015 Feb 26;372(9):825-34. doi: 10.1056/NEJMoa1408913.

40.

Prevalence of antimicrobial use in US acute care hospitals, May-September 2011.

Magill SS, Edwards JR, Beldavs ZG, Dumyati G, Janelle SJ, Kainer MA, Lynfield R, Nadle J, Neuhauser MM, Ray SM, Richards K, Rodriguez R, Thompson DL, Fridkin SK; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team.

JAMA. 2014 Oct 8;312(14):1438-46. doi: 10.1001/jama.2014.12923.

PMID:
25291579
41.

Clostridium difficile in the Pediatric Population of Monroe County, New York.

Rhee SM, Tsay R, Nelson DS, van Wijngaarden E, Dumyati G.

J Pediatric Infect Dis Soc. 2014 Sep;3(3):183-8. doi: 10.1093/jpids/pit091. Epub 2014 Jan 15.

PMID:
26625381
42.

The effect of multiple concurrent central venous catheters on central line-associated bloodstream infections.

Concannon C, van Wijngaarden E, Stevens V, Dumyati G.

Infect Control Hosp Epidemiol. 2014 Sep;35(9):1140-6. doi: 10.1086/677634. Epub 2014 Jul 28.

PMID:
25111922
43.

Sustained reduction of central line-associated bloodstream infections outside the intensive care unit with a multimodal intervention focusing on central line maintenance.

Dumyati G, Concannon C, van Wijngaarden E, Love TM, Graman P, Pettis AM, Greene L, El-Daher N, Farnsworth D, Quinlan G, Karr G, Ward L, Knab R, Shelly M.

Am J Infect Control. 2014 Jul;42(7):723-30. doi: 10.1016/j.ajic.2014.03.353. Epub 2014 May 23.

PMID:
24856587
44.

Multistate point-prevalence survey of health care-associated infections.

Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin SK; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team.

N Engl J Med. 2014 Mar 27;370(13):1198-208. doi: 10.1056/NEJMoa1306801.

45.

NAP1 strain type predicts outcomes from Clostridium difficile infection.

See I, Mu Y, Cohen J, Beldavs ZG, Winston LG, Dumyati G, Holzbauer S, Dunn J, Farley MM, Lyons C, Johnston H, Phipps E, Perlmutter R, Anderson L, Gerding DN, Lessa FC.

Clin Infect Dis. 2014 May;58(10):1394-400. doi: 10.1093/cid/ciu125. Epub 2014 Mar 5.

46.

Vital signs: improving antibiotic use among hospitalized patients.

Fridkin S, Baggs J, Fagan R, Magill S, Pollack LA, Malpiedi P, Slayton R, Khader K, Rubin MA, Jones M, Samore MH, Dumyati G, Dodds-Ashley E, Meek J, Yousey-Hindes K, Jernigan J, Shehab N, Herrera R, McDonald CL, Schneider A, Srinivasan A; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Mar 7;63(9):194-200.

47.

Clostridium difficile infection among children across diverse US geographic locations.

Wendt JM, Cohen JA, Mu Y, Dumyati GK, Dunn JR, Holzbauer SM, Winston LG, Johnston HL, Meek JI, Farley MM, Wilson LE, Phipps EC, Beldavs ZG, Gerding DN, McDonald LC, Gould CV, Lessa FC.

Pediatrics. 2014 Apr;133(4):651-8. doi: 10.1542/peds.2013-3049. Epub 2014 Mar 3.

PMID:
24590748
48.

Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile positivity rates across multiple laboratories in the United States.

Cohen J, Limbago B, Dumyati G, Holzbauer S, Johnston H, Perlmutter R, Dunn J, Nadle J, Lyons C, Phipps E, Beldavs Z, Clark LA, Lessa FC; CDC's Clostridium difficile Infection Surveillance Investigators.

J Clin Microbiol. 2014 Feb;52(2):632-4. doi: 10.1128/JCM.02177-13. Epub 2013 Nov 20.

49.

Inpatient costs, mortality and 30-day re-admission in patients with central-line-associated bloodstream infections.

Stevens V, Geiger K, Concannon C, Nelson RE, Brown J, Dumyati G.

Clin Microbiol Infect. 2014 May;20(5):O318-24. doi: 10.1111/1469-0691.12407. Epub 2013 Nov 6.

50.

Trends in invasive methicillin-resistant Staphylococcus aureus infections.

Iwamoto M, Mu Y, Lynfield R, Bulens SN, Nadle J, Aragon D, Petit S, Ray SM, Harrison LH, Dumyati G, Townes JM, Schaffner W, Gorwitz RJ, Lessa FC.

Pediatrics. 2013 Oct;132(4):e817-24. doi: 10.1542/peds.2013-1112. Epub 2013 Sep 23. Review.

PMID:
24062373

Supplemental Content

Loading ...
Support Center